Rapid screen for truncating ATM mutations by PTT-ELISA

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 640, Issue 1-2, 2008, Pages 139-144

  Du, Liutao ^a   Lai, Chih Hung ^a   Concannon, Patrick ^b   Gatti, Richard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Ataxia telangiectasia; ATM; ELISA; Protein Truncation Test; Truncating mutations

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; MYC PROTEIN;

AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA MUTATED GENE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE MUTATION; GENETIC SCREENING; GENETIC TRANSCRIPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRUNCATION TEST; RNA TRANSLATION; SCREENING TEST;

CELL CYCLE PROTEINS; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HETEROZYGOTE; HOMOZYGOTE; HUMANS; PROTEIN-SERINE-THREONINE KINASES; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 40649123039     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.01.002     Document Type: Article

References (29)

1. McKinnon P.J. ATM and ataxia telangiectasia. EMBO Rep. 5 (2004) 772-776
2. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., and Sfez S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 (1995) 1749-1753
3. Uziel T., Savitsky K., Platzer M., Ziv Y., Helbitz T., Nehls M., Boehm T., Rosenthal A., Shiloh Y., and Rotman G. Genomic organization of the ATM gene. Genomics 33 (1996) 317-320
4. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31 (2006) 402-410
5. Lavin M.F., Scott S., Gueven N., Kozlov S., Peng C., and Chen P. Functional consequences of sequence alterations in the ATM gene. DNA Repair (Amst.) 3 (2004) 1197-1205
6. Mitui M., Campbell C., Coutinho G., Sun X., Lai C.H., Thorstenson Y., Castellvi-Bel S., Fernandez L., Monros E., Carvalho B.T., Porras O., Fontan G., and Gatti R.A. Independent mutational events are rare in the ATM gene: haplotype prescreening enhances mutation detection rate. Hum. Mutat. 22 (2003) 43-50
7. Concannon P., and Gatti R.A. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum. Mutat. 10 (1997) 100-107
8. Coutinho G., Mitui M., Campbell C., Costa Carvalho B.T., Nahas S., Sun X., Huo Y., Lai C.H., Thorstenson Y., Tanouye R., Raskin S., Kim C.A., Llerena Jr. J., and Gatti R.A. Five haplotypes account for fifty-five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: seven new mutations. Am. J. Med. Genet. 126 (2004) 33-40
9. Telatar M., Wang Z., Udar N., Liang T., Bernatowska-Matuszkiewicz E., Lavin M., Shiloh Y., Concannon P., Good R.A., and Gatti R.A. Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. Am. J. Hum. Genet. 59 (1996) 40-44
10. Roest P.A., Roberts R.G., Sugino S., van Ommen G.J., and den Dunnen J.T. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum. Mol. Genet. 2 (1993) 1719-1721
11. van der L.R., Khan P.M., Vasen H., van L.C., Tops C., Roest P., den D.J., and Fodde R. Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 20 (1994) 1-4
12. den Dunnen J.T., van G.J., and Ommen. The protein truncation test: a review. Hum. Mutat. 14 (1999) 95-102
13. Kahmann S., Herter P., Kuhnen C., Müller K.M., Muhr G., Martin D., Soddemann M., and Müller O. A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations. Hum. Mutat. 19 (2002) 165-172
14. Rowan A.J., and Bodmer W.F. Introduction of a myc reporter tag to improve the quality of mutation detection using the protein truncation test. Hum. Mutat. 9 (1997) 172-176
15. Gite S., Lim M., Carlson R., Olejnik J., Zehnbauer B., and Rothschild K. A high-throughput nonisotopic protein truncation test. Nat. Biotechnol. 21 (2003) 194-197
16. Rothschild K.J., and Gite S. tRNA-mediated protein engineering. Curr. Opin. Biotechnol. 10 (1999) 64-70
17. Gite S., Mamaev S., Olejnik J., and Rothschild K. Ultrasensitive fluorescence-based detection of nascent proteins in gels. Anal. Biochem. 279 (2000) 218-225
18. Bernstein J.L., Bernstein L., Thompson W.D., Lynch C.F., Malone K.E., Teitelbaum S.L., Olsen J.H., Anton-Culver H., Boice J.D., Rosenstein B.S., Borresen-Dale A.L., Gatti R.A., Concannon P., and Haile R.W. ATM variants 7271T > G and IVS10-6T > G among women with unilateral and bilateral breast cancer. Br. J. Cancer 89 (2003) 1513-1516
19. Savitsky K., Sfez S., Tagle D.A., Ziv Y., Sartiel A., Collins F.S., Shiloh Y., and Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4 (1995) 2025-2032
20. Hentze M.W., and Kulozik A.E. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96 (1999) 307-310
21. Wilkinson M.F., and Shyu A.B. RNA surveillance by nuclear scanning?. Nat. Cell Biol. 4 (2002) E144-E147
22. Holbrook J.A., Neu-Yilik G., Hentze M.W., and Kulozik A.E. Nonsense-mediated decay approaches the clinic. Nat. Genet. 36 (2004) 801-808
23. Telatar M., Teraoka S., Wang Z., Chun H.H., Liang T., Castellvi-Bel S., Udar N., Borresen-Dale A.L., Chessa L., Bernatowska-Matuszkiewicz E., Porras O., Watanabe M., Junker A., Concannon P., and Gatti R.A. Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am. J. Hum. Genet. 62 (1998) 86-97
24. Telatar M., Wang S., Castellvi-Bel S., Tai L.Q., Sheikhavandi S., Regueiro J.R., Porras O., and Gatti R.A. A model for ATM heterozygote identification in a large population: four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia. Mol. Genet. Metab. 64 (1998) 36-43
25. Carter M.S., Doskow J., Morris P., Li S., Nhim R.P., Sandstedt S., and Wilkinson M.F. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J. Biol. Chem. 270 (1995) 28995-29003
26. Andreutti-Zaugg C., Scott R.J., and Iggo R. Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques. Cancer Res. 57 (1997) 3288-3293
27. Pitts S.A., Kullar H.S., Stankovic T., Stewart G.S., Last J.I., Bedenham T., Armstrong S.J., Piane M., Chessa L., Taylor A.M., and Byrd P.J. hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay. Hum. Mol. Genet. 10 (2001) 1155-1162
28. Lai C.H., Chun H.H., Nahas S.A., Mitui M., Gamo K.M., Du L., and Gatti R.A. Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15676-15681
29. Du L., Pollard J.M., and Gatti R.A. Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 6007-6012